Bank of Montreal Can Acquires 1,740 Shares of Sotera Health (NASDAQ:SHC)

Bank of Montreal Can raised its holdings in Sotera Health (NASDAQ:SHC) by 10.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,184 shares of the company’s stock after acquiring an additional 1,740 shares during the period. Bank of Montreal Can’s holdings in Sotera Health were worth $249,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Xponance Inc. grew its position in Sotera Health by 6.0% during the 4th quarter. Xponance Inc. now owns 17,495 shares of the company’s stock worth $239,000 after acquiring an additional 989 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Sotera Health by 2.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company’s stock worth $711,000 after purchasing an additional 1,047 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Sotera Health by 37.5% in the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock valued at $56,000 after buying an additional 1,121 shares during the period. Blue Trust Inc. boosted its position in Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock worth $25,000 after buying an additional 1,140 shares during the period. Finally, Envestnet Portfolio Solutions Inc. grew its holdings in Sotera Health by 17.3% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 15,839 shares of the company’s stock worth $217,000 after acquiring an additional 2,340 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $11.30 on Friday. The company has a market capitalization of $3.21 billion, a PE ratio of 45.20 and a beta of 1.88. The company has a quick ratio of 2.61, a current ratio of 2.88 and a debt-to-equity ratio of 4.91. Sotera Health has a twelve month low of $9.53 and a twelve month high of $17.08. The firm has a fifty day simple moving average of $11.61 and a 200 day simple moving average of $13.20.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on SHC. Barclays cut their price target on shares of Sotera Health from $16.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, April 10th. Piper Sandler cut their target price on Sotera Health from $15.00 to $13.00 and set a “neutral” rating on the stock in a report on Wednesday. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $15.20.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.